Close Menu

At Genetic Future, Daniel discusses a letter published in last week's Nature in which Kenneth Kosik and Francisco Lopera argue that, unlike a previous Nature article suggests, not all people are resilient when faced with bleak genetic test results, and the authors give an example of a man who stated he would shoot himself in the head if he knew he had the variant for Alz

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The US Food and Drug Administration is to announce stricter standards for emergency authorizations of SARS-CoV-2 vaccines, reports the Washington Post.

The Associated Press reports Johnson & Johnson is starting a late-stage clinical trial of its candidate SARS-CoV-2 vaccine.

Bloomberg reports the budget of Operation Warp Speed is actually $18 billion, higher than the number typically cited.

In Genome Research this week: genomic analysis reveals role of super-spreaders in SARS-CoV-2, epigenetic drivers of cancer, and more.